251 related articles for article (PubMed ID: 32723174)
1. Glucagon-like peptide-1 receptor mediates the beneficial effect of liraglutide in an acute lung injury mouse model involving the thioredoxin-interacting protein.
Zhou W; Shao W; Zhang Y; Liu D; Liu M; Jin T
Am J Physiol Endocrinol Metab; 2020 Sep; 319(3):E568-E578. PubMed ID: 32723174
[TBL] [Abstract][Full Text] [Related]
2. Effect of hCMSCs and liraglutide combination in ALI through cAMP/PKAc/β-catenin signaling pathway.
Feng Y; Wang L; Ma X; Yang X; Don O; Chen X; Qu J; Song Y
Stem Cell Res Ther; 2020 Jan; 11(1):2. PubMed ID: 31900217
[TBL] [Abstract][Full Text] [Related]
3. Liraglutide pretreatment attenuates sepsis-induced acute lung injury.
Baer B; Putz ND; Riedmann K; Gonski S; Lin J; Ware LB; Toki S; Peebles RS; Cahill KN; Bastarache JA
Am J Physiol Lung Cell Mol Physiol; 2023 Sep; 325(3):L368-L384. PubMed ID: 37489855
[TBL] [Abstract][Full Text] [Related]
4. CORM-2 inhibits TXNIP/NLRP3 inflammasome pathway in LPS-induced acute lung injury.
Jiang L; Fei D; Gong R; Yang W; Yu W; Pan S; Zhao M; Zhao M
Inflamm Res; 2016 Nov; 65(11):905-915. PubMed ID: 27412237
[TBL] [Abstract][Full Text] [Related]
5. Glucagon-like peptide-1 receptor activation alleviates lipopolysaccharide-induced acute lung injury in mice via maintenance of endothelial barrier function.
Xu J; Wei G; Wang J; Zhu J; Yu M; Zeng X; Wang H; Xie W; Kong H
Lab Invest; 2019 Apr; 99(4):577-587. PubMed ID: 30659271
[TBL] [Abstract][Full Text] [Related]
6. GABA requires GLP-1R to exert its pancreatic function during STZ challenge.
Shao W; Liu W; Liang P; Song Z; Israel O; Prud'homme GJ; Wang Q; Jin T
J Endocrinol; 2020 Sep; 246(3):207-222. PubMed ID: 32544878
[TBL] [Abstract][Full Text] [Related]
7. Endothelial GLP-1 (Glucagon-Like Peptide-1) Receptor Mediates Cardiovascular Protection by Liraglutide In Mice With Experimental Arterial Hypertension.
Helmstädter J; Frenis K; Filippou K; Grill A; Dib M; Kalinovic S; Pawelke F; Kus K; Kröller-Schön S; Oelze M; Chlopicki S; Schuppan D; Wenzel P; Ruf W; Drucker DJ; Münzel T; Daiber A; Steven S
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):145-158. PubMed ID: 31747801
[TBL] [Abstract][Full Text] [Related]
8. Glucagon-like Peptide-1 receptor Tie2+ cells are essential for the cardioprotective actions of liraglutide in mice with experimental myocardial infarction.
McLean BA; Wong CK; Kabir MG; Drucker DJ
Mol Metab; 2022 Dec; 66():101641. PubMed ID: 36396031
[TBL] [Abstract][Full Text] [Related]
9. Liraglutide protects against lethal renal ischemia-reperfusion injury by inhibiting high-mobility group box 1 nuclear-cytoplasmic translocation and release.
Li Y; Xu B; Yang J; Wang L; Tan X; Hu X; Sun L; Chen S; Zhu L; Chen X; Chen G
Pharmacol Res; 2021 Nov; 173():105867. PubMed ID: 34481074
[TBL] [Abstract][Full Text] [Related]
10. Liraglutide attenuates lipopolysaccharide-induced acute lung injury in mice.
Zhou F; Zhang Y; Chen J; Hu X; Xu Y
Eur J Pharmacol; 2016 Nov; 791():735-740. PubMed ID: 27756605
[TBL] [Abstract][Full Text] [Related]
11. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
12. Hepatic Fibroblast Growth Factor 21 Is Involved in Mediating Functions of Liraglutide in Mice With Dietary Challenge.
Liu D; Pang J; Shao W; Gu J; Zeng Y; He HH; Ling W; Qian X; Jin T
Hepatology; 2021 Oct; 74(4):2154-2169. PubMed ID: 33851458
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of glucagon-like peptide-1 receptor on epilepsy.
Wen Y; Wu K; Xie Y; Dan W; Zhan Y; Shi Q
Biochem Biophys Res Commun; 2019 Mar; 511(1):79-86. PubMed ID: 30770099
[TBL] [Abstract][Full Text] [Related]
14. Liraglutide Modulates Appetite and Body Weight Through Glucagon-Like Peptide 1 Receptor-Expressing Glutamatergic Neurons.
Adams JM; Pei H; Sandoval DA; Seeley RJ; Chang RB; Liberles SD; Olson DP
Diabetes; 2018 Aug; 67(8):1538-1548. PubMed ID: 29776968
[TBL] [Abstract][Full Text] [Related]
15. GDF15 acts synergistically with liraglutide but is not necessary for the weight loss induced by bariatric surgery in mice.
Frikke-Schmidt H; Hultman K; Galaske JW; Jørgensen SB; Myers MG; Seeley RJ
Mol Metab; 2019 Mar; 21():13-21. PubMed ID: 30685336
[TBL] [Abstract][Full Text] [Related]
16. The autonomic nervous system and cardiac GLP-1 receptors control heart rate in mice.
Baggio LL; Ussher JR; McLean BA; Cao X; Kabir MG; Mulvihill EE; Mighiu AS; Zhang H; Ludwig A; Seeley RJ; Heximer SP; Drucker DJ
Mol Metab; 2017 Nov; 6(11):1339-1349. PubMed ID: 29107282
[TBL] [Abstract][Full Text] [Related]
17. GLP-1 Analogue Liraglutide Enhances SP-A Expression in LPS-Induced Acute Lung Injury through the TTF-1 Signaling Pathway.
Zhu T; Li C; Zhang X; Ye C; Tang S; Zhang W; Sun J; Huang N; Wen F; Wang D; Deng H; He J; Qi D; Deng W; Yang T
Mediators Inflamm; 2018; 2018():3601454. PubMed ID: 29950925
[TBL] [Abstract][Full Text] [Related]
18. The active GLP-1 analogue liraglutide alleviates H9N2 influenza virus-induced acute lung injury in mice.
Bai Y; Lian P; Li J; Zhang Z; Qiao J
Microb Pathog; 2021 Jan; 150():104645. PubMed ID: 33285220
[TBL] [Abstract][Full Text] [Related]
19. Chrysin prevents lipopolysaccharide-induced acute lung injury in mice by suppressing the IRE1α/TXNIP/NLRP3 pathway.
Chen M; Li J; Liu X; Song Z; Han S; Shi R; Zhang X
Pulm Pharmacol Ther; 2021 Jun; 68():102018. PubMed ID: 33771723
[TBL] [Abstract][Full Text] [Related]
20. GLP-1 receptor agonist improves metabolic disease in a pre-clinical model of lipodystrophy.
Roumane A; Mcilroy GD; Sommer N; Han W; Heisler LK; Rochford JJ
Front Endocrinol (Lausanne); 2024; 15():1379228. PubMed ID: 38745956
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
